SEATTLE, Aug. 18, 2023 /PRNewswire/ — The Washington Poison Center (WAPC), Washington’s free medical service for questions and emergencies with medications, poisons, and drug overdoses, is pleased to announce the hiring of Justin Mauger, MA IE, BSW as its Eastern Washington Community…
Month: August 2023
DUBLIN, Aug. 18, 2023 /PRNewswire/ — The “RNA Therapy Clinical Trials Market, Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. The global RNA therapy clinical trials market size is expected to reach USD 3.5 billion by 2030. The market is expected to grow at a…
DUBLIN, Aug. 18, 2023 /PRNewswire/ — The “Global Transparent Electronics Market 2023-2027” report has been added to ResearchAndMarkets.com’s offering. The transparent electronics market is forecasted to grow by USD 4355.93 million during 2022-2027, accelerating at a CAGR of 30.71% during…
DUBLIN, Aug. 18, 2023 /PRNewswire/ — The “Virtual Reality (VR) Market Size, Share & Trends Analysis Report By Technology (Semi & Fully Immersive, Non-immersive), By Device (HMD, GTD), By Component (Hardware, Software), By Application, By Region, And Segment Forecasts, 2023 – 2030” report…
The notice is part of the compliance plan previously approved by Nasdaq. TuSimple intends to file the other delayed reports on or before the compliance date. SAN DIEGO, Aug. 18, 2023 /PRNewswire/ — TuSimple (Nasdaq: TSP) today announced that on Aug. 17, 2023, TuSimple Holdings Inc. (the…
COPPELL, Texas, Aug. 18, 2023 /PRNewswire/ — IDIS Co., Ltd. (“IDIS”) (143160:KOSDAQ) and Costar Technologies, Inc. (“Costar”) (OTC Markets Group: CSTI) are pleased to announce that pursuant to the terms of the previously announced merger agreement signed March 23, 2023 (the “Merger…
NEW YORK, Aug. 18, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Expensify, Inc. (“Expensify” or the “Company”) (NASDAQ: EXFY). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, Aug. 18, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, Aug. 18, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Hayward Holdings, Inc. (“Hayward” or the “Company”) (NYSE: HAYW). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
DUBLIN, Aug. 18, 2023 /PRNewswire/ — The “Europe Dialysis Devices Market By Product Type, By Application, By Disease Condition, By End User, By Country, Competition, Forecast & Opportunities, 2028” report has been added to ResearchAndMarkets.com’s offering. The Europe Dialysis Devices…